Naloxone Cloridrato Adulti Galenica Senese (Naloxone Hydrochloride Dihydrate)

Naloxone works by competitively binding to μ‑opioid receptors in the central nervous system, displacing opioid agonists such as morphine or fentanyl. This antagonism blocks further opioid activity, quickly reversing respiratory depression, sedation, and analgesia caused by the overdose.

The specific dose of naloxone is determined by the prescribing clinician based on the patient’s condition, the opioid involved, and the route of administration. In emergency practice, an initial dose is often given intravenously, intramuscularly, or subcutaneously, with additional doses administered if needed.

Safety data for naloxone in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

The primary alternative to naloxone is naltrexone, which is an oral opioid antagonist with a longer duration of action but slower onset. Naloxone provides rapid reversal of acute opioid toxicity, making it the preferred choice in emergency overdose situations, whereas naltrexone is used for maintenance therapy and relapse prevention.

Naloxone Cloridrato Adulti Galenica Senese should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the vials from direct light, moisture, and extreme temperatures to maintain potency and sterility.

Naloxone is administered by injection via the intramuscular, intravenous, or subcutaneous route. The choice of route depends on the clinical setting, the urgency of reversal, and the availability of vascular access. Proper aseptic technique and correct dosing are essential.

Serious risks include severe hypertension, cardiac arrhythmias, seizures, anaphylactic reactions, and pulmonary edema. These events are uncommon but require immediate medical attention. Monitoring of vital signs after administration is critical to detect any of these complications early.

Naloxone is contraindicated in patients with known hypersensitivity to naloxone or any of its excipients. It should also be used with caution in individuals with severe cardiovascular disease, as rapid reversal of opioid effects can precipitate abrupt changes in blood pressure and heart rate.